Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu‐Chin Liu, Chau‐Ting Yeh, Kwang‐Huei Lin
Cells (2020) Vol. 9, Iss. 6, pp. 1331-1331
Open Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells
Lianhong Pan, Fan Feng, Jiaqin Wu, et al.
Pharmacological Research (2022) Vol. 181, pp. 106270-106270
Closed Access | Times Cited: 214
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 156
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Junnv Xu, Haifeng Lin, Gang Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 137
Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
Dongjie Chen, Jixing Liu, Longjun Zang, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 1, pp. 360-373
Open Access | Times Cited: 106
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 65
Ubiquitous protein lactylation in health and diseases
Junyong Wang, Ziyi Wang, Q Wang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 36
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
Xinyue Zhang, Tianhong Su, Yifan Wu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 827-840
Closed Access | Times Cited: 33
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 31
MiRNA-mediated EMT and CSCs in cancer chemoresistance
Bing Dong, Shiyu Li, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
Megen C Wittling, Shannon R. Cahalan, Eric A. Levenson, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 59
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
Xiaomeng Dai, Yixuan Guo, Yan Hu, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3489-3501
Open Access | Times Cited: 58
The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
Joan Ericka Flores, Alexander Thompson, Marno Ryan, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 793-793
Open Access | Times Cited: 58
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment
Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, et al.
Molecular Imaging and Biology (2022) Vol. 25, Iss. 3, pp. 464-482
Closed Access | Times Cited: 55
Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing
Xinyue Li, Yue Shen, Li Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188720-188720
Closed Access | Times Cited: 53
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma
Kuo‐Shyang Jeng, Chiung‐Fang Chang, I-Shyang Sheen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1417-1417
Open Access | Times Cited: 32
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 32
Tumor matrix stiffness provides fertile soil for cancer stem cells
Sadegh Safaei, Roya Sajed, Ahmad Shariftabrizi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 14
CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling
Bo Hu, Yang Xu, Yuancheng Li, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 8
Open Access | Times Cited: 67
The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
Jingli Xu, Yuan Li, Yancheng Tang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival
Yong Li, Dandan Qi, Baoli Zhu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1474-1474
Open Access | Times Cited: 51
Mechanism of cancer stemness maintenance in human liver cancer
Ning Liang, Tao Yang, Qian Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 32
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment
Natascha Roehlen, Marion Müller, Zeina Nehme, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 343-355
Open Access | Times Cited: 30
A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories
Hao Zhang, Ting Wang, Haiyi Gong, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top